Adicet Bio (ACET) Stock Performance
Adicet Bio Inc. (ticker ACET) ended the trading session on Thursday, 22 March 2026, down 0.66 % to USD 4.49 at 01:14 PM Central European Time. The share price has declined 50.9 % from the end of the previous month.
Market Metrics
| Item | Value |
|---|---|
| Current share price | USD 4.49 |
| Market capitalization | USD 48.7 million |
| Total shares outstanding | 10.8 million |
| Trading volume (last 24 h) | USD 817.2 thousand |
| 200‑day simple moving average | USD 7.84 |
| 52‑week high | USD 14.98 (24 Oct 2025) |
| 52‑week low | USD 4.39 (19 Oct 2026) |
Recent Trading Activity
- Volume: 182,200 shares were traded in the past 24 hours, generating approximately USD 817.2 k in transaction value.
- Price trend: The stock has moved from USD 14.98 to USD 4.39 over the last year, reflecting a significant decline in investor demand.
Comparable Performance of Peer Stocks (24 h)
| Company | Ticker | % Change | Current Price | Market Cap |
|---|---|---|---|---|
| Eva Live | GOAI | +4.86 % | USD 1.51 | USD 58.3 million |
| Caribou Biosciences | CRBU | +4.82 % | USD 0.54 | USD 58.4 million |
| Grabagun Digital | PEW | 0 % | USD 1.96 | USD 57.9 million |
| Os Therapies | OSTX | +0.79 % | USD 1.27 | USD 58.2 million |
| Daxor | DXR | +0.21 % | USD 9.77 | USD 57 million |
| Key Ratio | P/E: 9.1 |
Company Overview
Adicet Bio Inc. is a clinical‑stage biopharmaceutical company headquartered in Boston, Massachusetts. The company focuses on developing off‑the‑shelf allogeneic γδ T‑cell therapies for cancer and other diseases on a global scale.